RAFFA WEALTH MANAGEMENT, LLC’s Legend Biotech LEGN Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462	Hold	16	–	–	﹤0.01%	1194
2026 Q1	$289	Hold	16	–	–	﹤0.01%	1127
2025 Q4	$348	Hold	16	–	–	﹤0.01%	1102
2025 Q3	$522	Hold	16	–	–	﹤0.01%	1061
2025 Q2	$568	Hold	16	–	–	﹤0.01%	975
2025 Q1	$543	Hold	16	–	–	﹤0.01%	944
2024 Q4	$521	Hold	16	–	–	﹤0.01%	999
2024 Q3	$780	Hold	16	–	–	﹤0.01%	904
2024 Q2	$709	Buy	+16	New	+$738	﹤0.01%	986

Other funds holding LEGN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ELI

Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

EFMH

E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TPSF

Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's LEGN Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Legend Biotech (LEGN) position steady in Q2 2026 at 16 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $780 in Q3 2024. 40 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 16 shares of Legend Biotech worth $462 as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC left its Legend Biotech share count unchanged in Q2 2026.
Legend Biotech made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1194 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Legend Biotech position peaked at $780 in Q3 2024.
40 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.